Safety update: Risdiplam clinical trial program for spinal muscular atrophy (SMA)

被引：1

作者：

Baranello, G. ^{[1
,2
,3
]}

Chiriboga, C. ^{[4
]}

Servais, L. ^{[5
,6
,7
,8
]}

Darras, B. ^{[9
]}

Day, J. ^{[10
]}

Deconinck, N. ^{[11
,12
]}

Farrar, M. ^{[13
,14
]}

Finkel, R. ^{[15
]}

Bertini, E. ^{[16
]}

Kirschner, J. ^{[17
]}

Rasson, M. ^{[3
]}

Mazurkiewicz-Beldzinska, M. ^{[18
]}

Vlodavets, D. ^{[19
]}

Bader-Weder, S. ^{[20
]}

Gorni, K. ^{[21
]}

Jaber, B. ^{[20
]}

Yeung, W. ^{[22
]}

Papp, G. ^{[20
]}

Scalco, R. ^{[23
]}

Mercuri, E. ^{[24
,25
]}

机构：

[1] UCL, NIHR Gt Ormond St Hosp, Dubowitz Neuromusc Ctr, Biomed Res Ctr,Gt Ormond St Inst Child Hlth, London, England

[2] Gt Ormond Str Hosp Trust, London, England

[3] Fdn IRCCS Ist Neurol Carlo Besta, Dev Neurol Unit, Milan, Italy

[4] Columbia Univ, Dept Neurol, Irving Med Ctr, New York, NY USA

[5] Univ Oxford, Dept Paediat, MDUK Oxford Neuromusc Ctr, Oxford, England

[6] Univ Hosp Liege, Div Child Neurol, Dept Paediat, Ctr References Malad Neuromusculaires, Liege, Belgium

[7] Univ Liege, Liege, Belgium

[8] Hop Armand Trousseau, AP HP, I Mot, Inst Myol, Paris, France

[9] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA USA

[10] Stanford Univ, Dept Neurol, Palo Alto, CA USA

[11] Univ Libre Bruxelles, Queen Fabiola Childrens Univ Hosp, Ctr Reference Malad Neuromusculaires, Brussels, Belgium

[12] UZ Gent, Neuromusc Reference Ctr, Ghent, Belgium

[13] Sydney Childrens Hosp Network, Sydney, NSW, Australia

[14] UNSW Sydney, UNSW Med, Sydney, NSW, Australia

[15] St Jude Childrens Res Hosp, Ctr Expt Neurotherapeut, Memphis, TN USA

[16] Bambino Gesu Childrens Res Hosp IRCCS, Res Unit Neuromusc & Neurodegen Disorders, Rome, Italy

[17] Univ Freiburg, Fac Med, Med Ctr, Dept Neuropaediat & Muscle Disorders, Freiburg, Germany

[18] Med Univ Gdansk, Dept Develt Neurol, Gdansk, Poland

[19] Pirogov Russian Nat Res Med Univ, Russian Children Neuromusc Ctr, Veltischev Clin Paed Res Inst, Moscow, Russia

[20] F Hoffmann La Roche Ltd, Pharma Dev Safety, Basel, Switzerland

[21] F Hoffmann La Roche Ltd, PDMA Neurosci & Rare Dis, Basel, Switzerland

[22] Roche Prod Ltd, Welwyn Garden City, Herts, England

[23] F Hoffmann La Roche Ltd, Pharma Dev Neurol, Basel, Switzerland

[24] Catholic Univ, Paediat Neurol Inst, Rome, Italy

[25] Fdn Policlin Gemelli IRCCS, Nemo Pediat, Rome, Italy

来源：

NEUROMUSCULAR DISORDERS | 2023年 / 33卷

关键词：

D O I：

10.1016/j.nmd.2023.07.112

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P230

引用

页码：S92 / S93

页数：2

共 50 条

[21] FIREFISH Parts 1 and 2: 4-year efficacy and safety of risdiplam in Type 1 spinal muscular atrophy (SMA)
Mazurkiewicz-Beldzinska, M.
Baranello, G.
Boespflug-Tanguy, O.
Day, J.
Deconinck, N.
Klein, A.
Masson, R.
Mercuri, E.
Rose, K.
Servais, L.
Vlodavets, D.
Xiong, H.
Zanoteli, E.
El-Khairi, M.
Gerber, M.
Gorni, K.
Kletzl, H.
Palfreeman, L.
Dodman, A.
Darras, B.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 196 - 196
[22] Long-term comparative efficacy and safety of risdiplam versus nusinersen in children with Type 1 spinal muscular atrophy (SMA)
Sajeev, G.
Evans, R.
Hawkins, N.
Mahajan, A.
Scott, D.
Nam, J.
Sutherland, S.
Kokaliaris, C.
NEUROMUSCULAR DISORDERS, 2023, 33 : S164 - S164
[23] FIREFISH Part 2: 24-month Efficacy and Safety of Risdiplam in Infants with Type 1 Spinal Muscular Atrophy (SMA)
Darras, Basil T.
Masson, Ricardo z
Mazurkiewicz-Beldzinska, Maria
Rose, Kristy
Xiong, Hui
Zanoteli, Edmar
Baranello, Giovanni
Vlodavets, Dmitry
Dodman, Angela
El-Khairi, Muna
Gerber, Marianne
Gorni, Ksenija
Kletzl, Heidemarie
Scalco, Renata S.
Servais, Laurent
NEUROLOGY, 2021, 96 (15)
[24] FIREFISH Part 2: Efficacy and Safety of Risdiplam (RG7916) in Infants with Type 1 Spinal Muscular Atrophy (SMA)
Servais, Laurent
Baranello, Giovanni
Masson, Riccardo
Mazurkiewicz-Beldzinska, Maria
Rose, Kristy
Vlodavets, Dmitry
Xiong, Hui
Zanoteli, Edmar
El-Khairi, Muna
Fuerst-Recktenwald, Sabine
Gerber, Marianne
Gorni, Ksenija
Kletzl, Heidemarie
Scalco, Renata
Darras, Basil T.
NEUROLOGY, 2020, 94 (15)
[25] FIREFISH Part 2: Efficacy and safety of risdiplam (RG7916) in infants with Type 1 spinal muscular atrophy (SMA)
Baranello, Giovanni
Servais, Laurent
Masson, Riccardo
Mazurkiewicz-Beldzinska, Maria
Rose, Kristy
Vlodavets, Dmitry
Xiong, Hui
Zanoteli, Edmar
El-Khairi, Muna
Fuerst-Recktenwald, Sabine
Gerber, Marianne
Gorni, Ksenija
Kletzl, Heidemarie
Scalco, Renata
Darras, Basil T.
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[26] IREFISH Parts 1 and 2: 24-month safety and efficacy of risdiplam in type 1 spinal muscular atrophy (SMA)
Masson, R.
Boespflug-Tanguy, O.
Darras, B.
Day, J.
Deconinck, N.
Klein, A.
Mazurkiewicz-Beldzinska, M.
Mercuri, E.
Rose, K.
Servais, L.
Vlodavets, D.
Xiong, H.
Zanoteli, E.
Dodman, A.
El-Khairi, M.
Gaki, E.
Gerber, M.
Gorni, K.
Kletzl, H.
Baranello, G.
NEUROMUSCULAR DISORDERS, 2021, 31 : S134 - S134
[27] JEWELFISH: Safety, pharmacodynamic and exploratory efficacy data in non-naive patients with spinal muscular atrophy (SMA) receiving risdiplam
Chiriboga, C.
Bruno, C.
Duong, T.
Fischer, D.
Kirschner, J.
Mercuri, E.
Gerber, M.
Gorni, K.
Kletzl, H.
Carruthers, I.
Martin, C.
Warren, F.
Scoto, M.
NEUROMUSCULAR DISORDERS, 2021, 31 : S134 - S135
[28] FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA)
Darras, Basil
Baranello, Giovanni
Boespflug-Tanguy, Odile
Day, John
Deconinck, Nicholas
Klein, Andrea
Masson, Ricardo
Mazurkiewicz-Beldzinska, Maria
Mercuri, Eugenio
Rose, Kristy
Vlodavets, Dmitry
Xiong, Hui
Zanoteli, Edmar
El-Khairi, Muna
Gerber, Marianne
Gorni, Ksenija
Kletzl, Heidemarie
Palfreeman, Laura
Dodman, Angela
Servais, Laurent
NEUROLOGY, 2023, 100 (17)
[29] FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA)
Servais, L.
Baranello, G.
Boespflug-Tanguy, O.
Day, J.
Deconinck, N.
Klein, A.
Masson, R.
Mazurkiewicz-Beldzinska, M.
Mercuri, E.
Rose, K.
Vlodavets, D.
Xiong, H.
Zanoteli, E.
El-Khairi, M.
Gerber, M.
Gorni, K.
Kletzl, H.
Palfreeman, L.
Dodman, A.
Gaki, E.
Darras, B.
NEUROMUSCULAR DISORDERS, 2022, 32 : S88 - S88
[30] FIREFISH Part 2: Efficacy and safety of risdiplam (RG7916) in infants with Type 1 spinal muscular atrophy (SMA)
Servais, L.
Baranello, G.
Masson, R.
Mazurkiewicz-Beldzinska, M.
Rose, K.
Vlodavets, D.
Xiong, H.
Zanoteli, E.
El-Khairi, M.
Fuerst-Recktenwald, S.
Gerber, M.
Gorni, K.
Kletzl, H.
Scalco, R.
Darras, B. T.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 166 - 167

← 1 2 3 4 5 →